Should Dissociative-Dose Ketamine Be Co-Administered with Benzodiazepines?
Yes, benzodiazepines should be co-administered with dissociative-dose ketamine to reduce emergence reactions, which occur in approximately 12% of patients and can include hallucinations, confusion, and agitation. 1
FDA-Approved Strategy for Emergence Reaction Prevention
The FDA label for ketamine explicitly states that the incidence of psychological manifestations during emergence, particularly dream-like observations and emergence delirium, may be reduced by using lower recommended dosages of ketamine hydrochloride in conjunction with an intravenous benzodiazepine during induction and maintenance of anesthesia. 1 This represents the highest-level regulatory guidance available and should direct clinical practice.
Clinical Evidence Supporting Co-Administration
Multiple studies demonstrate that concurrent benzodiazepine administration effectively prevents psychotomimetic side effects without compromising ketamine's analgesic or sedative properties:
A 1997 pediatric study of 350 procedures using midazolam (0.05–0.1 mg/kg IV) followed by ketamine (1–2 mg/kg IV) found the combination safe and effective, with only 2 patients experiencing significant agitation during recovery—one resolving spontaneously and one responding to diphenhydramine. 2
A 2002 pain management series demonstrated that starting ketamine at low doses (40–60 mg over 24 hours) concurrently with a benzodiazepine proved effective in preventing psychotomimetic side effects. 3
A 2004 study of subanesthetic ketamine with diazepam for outpatient procedures showed no statistical difference in hallucinatory reactions compared to fentanyl-based sedation when benzodiazepines were included. 4
A 2004 trial specifically noted that ketamine adverse effects (hallucinosis, nystagmus, photophobia, psychomotor excitation, psychotic symptoms) could be reduced by intraoperative administration of benzodiazepines. 5
Dosing Algorithm
For procedural sedation in adults:
- Administer midazolam 0.05–0.1 mg/kg IV (maximum single dose 2 mg, maximum total 4 mg) first 2
- Follow with ketamine 1–2 mg/kg IV for dissociative sedation 2
- For prolonged procedures, give additional ketamine 0.5–1 mg/kg as needed 2
For chronic pain management:
- Start ketamine at 40–60 mg over 24 hours concurrently with a benzodiazepine 3
- This prevents emergence phenomena while maintaining analgesic efficacy
Important Safety Considerations
The FDA warns that concomitant use of ketamine with benzodiazepines or other CNS depressants may result in profound sedation and respiratory depression. 1 Therefore:
- Closely monitor neurological status and respiratory parameters, including respiratory rate and pulse oximetry 1
- Have oxygen, suction, and airway rescue equipment immediately available 6
- Ensure a second staff member trained in airway management is present 2
- Monitor vital signs continuously during the procedure and recovery 2
Common Pitfalls to Avoid
Do not omit benzodiazepines in an attempt to avoid respiratory depression—the risk of distressing emergence reactions (12% incidence) 1 outweighs the manageable risk of respiratory depression when proper monitoring is in place. The 1997 pediatric study showed only transient oxygen desaturation in 4/350 procedures, all resolved with temporary interruption and blow-by oxygen. 2
Do not use excessive benzodiazepine doses—the goal is emergence reaction prophylaxis, not deep sedation. Midazolam 0.05–0.1 mg/kg is sufficient. 2
Minimize environmental stimulation during recovery—verbal, tactile, and visual stimulation should be reduced (while maintaining vital sign monitoring) to further decrease emergence reactions. 1
Guideline Context
The 2019 multidisciplinary consensus guideline on procedural sedation emphasizes that no single sedative agent or combination is ideal for every patient or procedure, and regimens must be customized. 6 However, the guideline specifically notes that dissociative sedation with ketamine helps preserve protective airway reflexes and has no reported aspiration events in healthy patients receiving ketamine alone. 6 The addition of benzodiazepines does not negate these protective properties when used at appropriate doses with proper monitoring.